Nektar Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NKTR and other ETFs, options, and stocks.

About NKTR

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit.

CEO

Howard W. Robin

CEOHoward W. Robin

Employees

Employees61

Headquarters

San Francisco, California

HeadquartersSan Francisco, California

Founded

1990

Founded1990

Employees

Employees61

NKTR Key Statistics

Market cap

144.25M

Market cap144.25M

Price-Earnings ratio

-1.33

Price-Earnings ratio-1.33

Dividend yield

—

Dividend yield—

Average volume

2.64M

Average volume2.64M

High today

$0.8099

High today$0.8099

Low today

$0.74

Low today$0.74

Open price

$0.7533

Open price$0.7533

Volume

3.04M

Volume3.04M

52 Week high

$1.93

52 Week high$1.93

52 Week low

$0.432

52 Week low$0.432

Analyst ratings

75%

of 8 ratings

Buy

75%

Hold

12.5%

Sell

12.5%